All filters
Slidesets
(Abstract) Cost-efficiency versus Potency | Anca Streinu-Cercel, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Ukraine | Pavlo Skala
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in the Baltic countries | Saulius Caplinskas, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Slovenia and the Balcan countries | Mojca Maticic, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Poland | Miłosz Parczewski, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Czech and Slovak Republics | Viktor Aster, MD, PHD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Georgia | Akaki Abutidze, MD, MPH, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Pharmacokinetic, Safety and Efficacy of Darunavir/Ritonavir in HIV+ Pregnant Women - Dr. Minh Patrick Le
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Raltegravir (RAL) Pharmacokinetics (PK) and Safety in HIV-1 Exposed Neonates at High Risk of Infection (IMPAACT P1110) - Dr. Diana Clarke
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Timing of the postpartum curve in pharmacokinetic studies in pregnancy should not be too early - Angela Colbers, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Other Viruses: using Wolbachia to interrupt transmission of viral infections such as Dengue, Chikungunya and Zika - Steven Kern, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Effect of Renal Impairment on Drugs Primarily Eliminated by Metabolism or Biliary Excretion: Review of Data from HCV DAA Drugs and Literature - Dr. Tushar Garimella
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Effect of daclatasvir/asunaprevir/beclabuvir in fixed-dose combination on the pharmacokinetics of CYP450/transporter substrates in healthy subjects- Dr. Tushar Garimella
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
The FDA Perspective on Hepatitis C Drug Resistance - Patrick Harrington, PHD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Cumulative tenofovir exposure is associated with decreased BMD in young and old HIV-infected adults on tenofovir based regimens - Sharon Seifert, PhramD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Evaluation of Drug-Drug Interaction Between Sofosbuvir/Velpatasvir and Rifaximin in HCV-Infected Subjects with Moderate Hepatic Impairment - Erik Mogalian
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Intracellular Metabolism of Tenofovir Alafenamide in Cervical and Vaginal Epithelial Cells - Mackenzie Cottrell, PharmD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Pharmacogenetics of Efavirenz Discontinuation for Central Nervous System Symptoms at a Southeastern United States Clinic May Differ by Race - Paul Leger, MD, MPH
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Virologic and Immunologic Responses to Raltegravir and Dolutegravir in GALT of HIV+ Men and Women - Michael Weber, PharmD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
FDA Perspective on "oral run-in" phase - Dr. Yodit Belew
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
ViiV - Cabotegravir - Bill Spreen, PharmD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Target Concentrations - Angela Kashuba, PharmD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016